Regression of ECG-LVH is Associated with Lower Risk of New-Onset Heart Failure and Mortality in Patients with Isolated Systolic Hypertension; The LIFE Study | Zendy

Anne Cecilie K. Larstorp | Zendy; Peter M. Okin | Zendy; Richard B. Devereux | Zendy; Michael Hecht Olsen | Zendy; Hans Ibsen | Zendy; Björn Dahlöf | Zendy; Sverre E. Kjeldsen | Zendy; Kristian Wachtell | Zendy

Open Access

Regression of ECG-LVH is Associated with Lower Risk of New-Onset Heart Failure and Mortality in Patients with Isolated Systolic Hypertension; The LIFE Study

Author(s) -

Anne Cecilie K. Larstorp,

Peter M. Okin,

Richard B. Devereux,

Michael Hecht Olsen,

Hans Ibsen,

Björn Dahlöf,

Sverre E. Kjeldsen,

Kristian Wachtell

Publication year - 2012

Publication title -

american journal of hypertension

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.009

H-Index - 136

eISSN - 1941-7225

pISSN - 0895-7061

DOI - 10.1038/ajh.2012.86

Subject(s) - medicine , cardiology , hazard ratio , losartan , heart failure , atenolol , left ventricular hypertrophy , proportional hazards model , blood pressure , diastole , confidence interval , angiotensin ii

Hypertension and electrocardiographic left ventricular hypertrophy (ECG-LVH) are strong predictors of heart failure (HF). It is unclear whether regression of ECG-LVH during treatment predicts less new-onset HF in patients with isolated systolic hypertension (ISH).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research